Related Experiment Videos
Homocystine solubility and vascular disease
1Department of Biochemistry and Biophysics-CRISCEB, Second University of Naples, 80138 Naples, Italy. ragone@unina2.it
Summary
Mild elevations in total homocysteine (tHcy) increase vascular disease risk. This study hypothesizes that homocysteine oxidation to homocystine causes cellular toxicity and endothelial damage, potentially leading to thrombosis and stroke.
Area of Science:
- Biochemistry
- Vascular Biology
- Pathophysiology
Background:
- Mild elevations in total plasma homocysteine (tHcy) are linked to increased risks of occlusive vascular disease, thrombosis, and stroke.
- The precise mechanisms underlying this association remain incompletely understood, particularly regarding cellular toxicity.
Purpose of the Study:
- To hypothesize that cellular toxicity from homocysteine auto-oxidation to homocystine contributes to vascular risk.
- To propose that elevated tHcy levels directly cause endothelial damage via homocystine precipitation.
Main Methods:
- Literature review and theoretical analysis of homocysteine metabolism and solubility.
- Comparison of homocysteine's potential precipitation mechanism with known cystine precipitation in cystinosis/cystinuria.
Main Results:
- Homocysteine circulates primarily as oxidation products, with homocystine being poorly soluble at neutral pH.
- Normal plasma homocysteine levels approach the saturation limit for homocystine.
- Transient increases in homocysteine could lead to homocystine microcrystal precipitation in blood.
Conclusions:
- Homocystine microcrystals may precipitate in the bloodstream, causing endothelial damage.
- This precipitation could act as a "mechanic primer" for prothrombotic vascular alterations.
- Elevated tHcy may be a primary cause of vascular risk through this proposed mechanism.